Last reviewed · How we verify

NCT03768661

Incisional Hernia Rate After Single-incision Laparoscopic Cholecystectomy

Completed Last updated 14 April 2020
What this trial tests

trial testing Single-incision Laparoscopic cholecystectomy in Cholelithiasis in 185 participants. Completed in 1 November 2017.

Timeline
1 July 2009
Primary endpoint
30 June 2011
1 November 2017

Quick facts

Lead sponsorHospital Plató
StatusCompleted
Study typeOBSERVATIONAL
Enrollment185
Start date1 July 2009
Primary completion30 June 2011
Estimated completion1 November 2017
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Hospital Plató

Who can join

18 and older, any sex, with Cholelithiasis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Single-incision laparoscopic cholecystectomy (SILC) requires a larger incision than standard laparoscopy, which may increase the incidence of incisional hernias. This study evaluated SILC and standard multiport cholecystectomy with respect to perioperative outcomes, hospital stay, cosmetic results, and postoperative complications, including the 5-years incisional hernia rate.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Long-term incisional hernia rate after single-incision laparoscopic cholecystectomy is significantly higher than that after standard three-port laparoscopy: a cohort study.
    Hoyuela C, Juvany M, Guillaumes S, Ardid J, et al · · 2019 · cited 27× · PMID 31073959 · DOI 10.1007/s10029-019-01969-x

Verify or expand the search:

Other recruiting trials for Cholelithiasis

Currently open trials in the same condition.

Other Hospital Plató trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03768661.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing